No Data
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced From Linea DNA
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday
10-K: FY2024 Annual Report
Applied DNA Sciences Announces Leadership Changes and Restructuring
Applied DNA Sciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Sales Results and Announced Plans for a Strategic Restructuring of Operations Including Divestiture of Certain Business Segments.
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
